Ciprofloxacin is one of the most prescribed antibiotics in the United States. It is also one of the most dangerous, carrying two FDA black box warnings, an aortic aneurysm risk warning, and a history of permanently disabling patients who were told the drug was safe for routine infections. Thousands of lawsuits have been filed against Bayer and other manufacturers. Many more patients never knew the drug was to blame. If you have taken ciprofloxacin and experienced tendon damage, nerve pain, or cardiovascular emergencies, this is what you need to know.
What Is Ciprofloxacin
Ciprofloxacin is a broad-spectrum antibiotic approved by the FDA in 1987. It belongs to a class of antibiotics called fluoroquinolones, which also includes levofloxacin (Levaquin), moxifloxacin (Avelox), and ofloxacin. The brand-name version of ciprofloxacin is Cipro, manufactured by Bayer Healthcare Pharmaceuticals. Generic versions are made by Teva (formerly Actavis), Mylan, and other manufacturers.
Ciprofloxacin works by blocking two bacterial enzymes, DNA gyrase and topoisomerase IV, that bacteria need to copy their DNA. Without those enzymes, bacteria cannot replicate and die.
What Ciprofloxacin Is Prescribed For
Ciprofloxacin is FDA-approved for a wide range of bacterial infections:
- Urinary tract infections, including complicated kidney infections (pyelonephritis)
- Bone and joint infections
- Skin and soft tissue infections
- Prostatitis
- Pneumonia and lower respiratory tract infections
- Typhoid fever and gastrointestinal infections
- Inhalation anthrax (post-exposure prevention, including the 2001 bioterrorism attacks)
- Plague
- Eye infections (as eye drops) and ear infections (as ear drops)
The drug gained cultural prominence as the anthrax antibiotic after the 2001 U.S. mail attacks. That association with a life-saving emergency application helped cement its reputation as a go-to antibiotic, including for routine infections where far safer alternatives exist.
The FDA has specifically warned that ciprofloxacin should NOT be used for uncomplicated sinusitis, uncomplicated urinary tract infections, or acute bronchitis when other antibiotic options are available, because the serious risks of the drug outweigh the benefits for those routine indications. Many patients still receive it for exactly these conditions.
The Two FDA Black Box Warnings for Ciprofloxacin
A black box warning is the FDA’s highest-level drug safety warning, placed in a bordered black box at the top of the prescribing information. Ciprofloxacin carries two of them. Most patients are never shown these warnings.
Black Box Warning 1: Tendinitis and Tendon Rupture (Added 2008)
The FDA added this warning in 2008 after accumulating evidence that ciprofloxacin and other fluoroquinolones caused tendon damage at rates that could not be dismissed as coincidence or underlying disease.
Tendinitis is inflammation of the tendon. Tendon rupture is a complete or partial tear, which often requires surgery and results in permanent weakness or loss of function. The Achilles tendon is the most commonly affected, but ruptures have also occurred in the shoulder, hand, bicep, and thumb tendons.
Three features of this risk make it especially dangerous:
Delayed onset. Tendon damage can occur during treatment, but also weeks to months after stopping the drug. Patients who took a ten-day course of ciprofloxacin and feel fine when they finish the prescription may rupture their Achilles tendon playing recreational sports six months later and have no reason to connect it to a drug they stopped taking half a year ago.
Sudden rupture. Unlike some degenerative tendon conditions that give warning signs, ciprofloxacin-induced tendon rupture can occur without warning during ordinary activities including walking.
High-risk groups. The risk is highest in patients over 60, those currently taking corticosteroids (prednisone and related drugs), and organ transplant recipients. For patients in these categories, the FDA warning is explicit: the use of fluoroquinolones should be avoided unless no alternative exists.
Black Box Warning 2: Peripheral Neuropathy (Added August 2013)
In 2013, the FDA upgraded the peripheral neuropathy warning from a standard precaution to a full black box warning after evidence accumulated that ciprofloxacin and other fluoroquinolones could cause nerve damage that was not temporary.
Peripheral neuropathy is damage to the nerves outside the brain and spinal cord, affecting sensation and movement in the limbs. Symptoms include burning pain, tingling, numbness, weakness, and hypersensitivity to touch. The 2013 black box warning states explicitly that these symptoms “may be irreversible.”
The critical legal detail: before 2013, Bayer’s labeling described the neuropathy risk as “rare” and “generally reversible.” Internal evidence developed during litigation showed that manufacturers knew by at least 1996 that fluoroquinolone-induced neuropathy could be prolonged and potentially permanent. The failure to warn adequately for over fifteen years formed the core of the peripheral neuropathy lawsuits.
Additional FDA Warnings: Mental Health, Blood Sugar, and Aortic Rupture
Beyond the two black box warnings, the FDA has issued a series of additional safety communications for ciprofloxacin that many patients and prescribers are unaware of.
Mental Health and Blood Sugar (July 10, 2018)
The FDA issued a drug safety communication on July 10, 2018, warning that fluoroquinolones, including ciprofloxacin, can cause serious mental health side effects and dangerous blood sugar disturbances:
Psychiatric effects: Anxiety, agitation, depression, insomnia, memory impairment, hallucinations, paranoia, suicidal thoughts, and toxic psychosis. These effects can occur after a single dose.
Hypoglycemia: Dangerously low blood sugar, including cases resulting in coma and death. The risk is highest in diabetic patients taking oral diabetes medications (sulfonylureas) or insulin concurrently with ciprofloxacin.
CNS effects: Seizures, increased intracranial pressure (which can cause vision changes and severe headache), and toxic psychosis have all been documented.
Aortic Aneurysm and Dissection (December 20, 2018)
On December 20, 2018, the FDA issued a formal Drug Safety Communication warning that fluoroquinolones, including ciprofloxacin, are associated with rare but life-threatening ruptures or tears of the main artery of the body, the aorta. The FDA had identified 71 cases of aortic aneurysm or dissection in fluoroquinolone users in its adverse event database, 56 of them occurring between 2015 and 2018.
Aortic dissection is a tear in the inner layer of the aortic wall that allows blood to flood between the wall layers. It is a surgical emergency with a mortality rate that rises sharply with every hour that passes before surgery. Aortic aneurysm is an abnormal bulge in the aortic wall that can rupture without warning.
Multiple peer-reviewed studies support the FDA’s concern:
- A 2018 study in the Journal of the American College of Cardiology found a significant association between fluoroquinolone use and aortic dissection risk
- JAMA Internal Medicine and JAMA Surgery published studies in 2020 finding meaningful associations between fluoroquinolone use and aortic aneurysm development
- A 2025 multinational retrospective cohort study published in The Lancet eClinicalMedicine confirmed the association across multiple countries and healthcare systems
- Research indicates the highest-risk window is within 60 days of taking a fluoroquinolone, with some studies finding a two-to-three-fold increased risk during that period
The proposed mechanism involves collagen and elastin disruption in the aortic wall. Fluoroquinolones appear to affect the enzymes that regulate connective tissue integrity, weakening the structural layers of the aorta.
Highest-risk patients for aortic complications:
- Those with pre-existing aortic aneurysm or family history of aortic disease
- Patients with hypertension
- Those with Marfan syndrome or Ehlers-Danlos syndrome
- Elderly patients over 65
Myasthenia Gravis Warning (February 2011)
Fluoroquinolones can cause life-threatening worsening of muscle weakness in patients with myasthenia gravis, including cases requiring mechanical ventilation. Patients with myasthenia gravis should not take ciprofloxacin unless no alternative exists.
Fluoroquinolone Toxicity Syndrome: When Everything Goes Wrong at Once
Some patients experience what has come to be called fluoroquinolone-associated disability, or FQAD, sometimes informally called “being floxed.” This describes a pattern in which a patient taking a fluoroquinolone develops multi-system damage affecting tendons, nerves, muscles, joints, the cardiovascular system, and sensory organs simultaneously or in rapid sequence.
The FDA defines FQAD as serious adverse effects lasting at least 30 days after the final dose. In practice, patients report symptoms lasting far longer. The FDA’s average documented case duration was 14 months. Patient testimonials describe symptoms persisting for 5, 7, and 9 or more years.
Documented FQAD symptoms span multiple body systems:
- Tendons and musculoskeletal: tendinitis, ruptures, joint pain, muscle wasting
- Nervous system: burning neuropathy, cognitive impairment, memory loss, anxiety, depression
- Cardiovascular: chest pain, palpitations, QT prolongation, dangerous arrhythmias
- Sensory: eye pain, vision deterioration, hearing loss, tinnitus
- Skin: photosensitivity, hair loss
The mechanism of FQAD is not fully understood. Current research points to mitochondrial damage and disruption of collagen synthesis as contributing factors. Fluoroquinolones appear to penetrate mitochondria and inhibit mitochondrial DNA replication, creating cellular energy deficits across multiple tissues simultaneously.
Patients who are athletes, physically active, over 60, on corticosteroids, or have high cholesterol appear to be at elevated risk for severe fluoroquinolone toxicity.
Who Should Not Take Ciprofloxacin
The following populations carry elevated risk and in many cases should not be prescribed ciprofloxacin when alternatives exist:
- Patients with known allergy or hypersensitivity to any fluoroquinolone
- Patients taking tizanidine (Zanaflex), this combination is an absolute contraindication due to risk of life-threatening low blood pressure and respiratory depression
- Patients with myasthenia gravis
- Patients with existing or suspected aortic aneurysm
- Patients with long QT syndrome or taking other QT-prolonging medications
- Patients over 60 taking corticosteroids (the black box warning specifically names this combination)
- Organ transplant recipients on corticosteroids
- Pregnant women (particularly in the second and third trimesters)
- Breastfeeding mothers
Ciprofloxacin Drug Interactions
Ciprofloxacin interacts with a significant number of commonly prescribed drugs. Major interactions include:
Tizanidine (Zanaflex): Absolute contraindication. Ciprofloxacin dramatically increases tizanidine blood levels, causing dangerous drops in blood pressure and sedation.
Warfarin: Significantly potentiates the blood-thinning effect, elevating bleeding risk. INR must be monitored closely.
Duloxetine (Cymbalta): Ciprofloxacin can increase duloxetine levels up to five-fold, raising the risk of serotonin syndrome and toxicity.
Theophylline: Ciprofloxacin inhibits the metabolism of theophylline (used for asthma and COPD), causing toxicity at normal doses.
QT-prolonging drugs: Combining ciprofloxacin with other QT-prolonging medications (amiodarone, quinidine, certain antipsychotics, certain antidepressants, and macrolide antibiotics) creates additive cardiac risk.
Oral diabetes medications (sulfonylureas, insulin): Combined use increases the risk of life-threatening hypoglycemia.
NSAIDs (ibuprofen, naproxen): At high ciprofloxacin doses, this combination increases seizure risk.
Antacids, dairy products, calcium, iron, zinc supplements: These reduce ciprofloxacin absorption and should not be taken within two hours of a dose.
The Ciprofloxacin Lawsuit History
Tendon Rupture Cases and MDL (2008 Onward)
Following the 2008 black box warning, patients who suffered Achilles tendon rupture and other tendon injuries began filing lawsuits against Bayer (for brand-name Cipro) and Johnson & Johnson’s subsidiary Janssen (for Levaquin). A federal multidistrict litigation for tendon rupture cases was consolidated in the District of Minnesota, before Judge John R. Tunheim.
More than 2,049 federal tendon rupture cases were eventually filed. A separate New Jersey state court mass tort docket handled over 1,700 additional cases. The New Jersey docket closed in July 2017. The federal MDL cases resolved through confidential individual settlements; no announced global settlement amount has been publicly confirmed.
The first bellwether trial in the Levaquin litigation (a closely related fluoroquinolone), concluded in December 2010 with a jury verdict of $700,000 in compensatory damages and $1.115 million in punitive damages against Johnson & Johnson. The jury found the company acted with deliberate disregard for patient safety. The punitive portion was reduced on appeal, but the verdict established that juries were willing to find against fluoroquinolone manufacturers.
Peripheral Neuropathy MDL 2642 (2015 to 2024)
A second MDL for peripheral neuropathy cases was established in Minnesota federal court in August 2015 as MDL No. 2642. Evidence developed during the litigation showed that manufacturers were aware as far back as 1996 that fluoroquinolone-induced neuropathy could be prolonged and potentially permanent, contrary to the “rare” and “reversible” language on their labels prior to 2013.
Approximately 1,270 cases alleging permanent peripheral nerve damage were consolidated or pending in the MDL. By July 2024, only four active lawsuits remained. The parties had entered settlement mediation and resolved the bulk of cases. Most plaintiff law firms stopped accepting new ciprofloxacin peripheral neuropathy cases by 2024, both because the MDL was winding down and because statutes of limitations had expired for many potential claimants.
Aortic Aneurysm and Dissection Lawsuits: The Active Frontier
Following the FDA’s December 2018 aortic warning, patients who suffered aortic aneurysm or dissection after taking fluoroquinolones began filing lawsuits. These cases allege that Bayer and other manufacturers possessed evidence of the aortic risk before the FDA’s 2018 warning and failed to disclose it to patients and prescribers.
Unlike the tendon and neuropathy MDLs, no federal MDL has been established for aortic aneurysm claims. Cases are proceeding individually and in state courts. Aortic dissection and aneurysm cases remain the most actively accepted category of fluoroquinolone litigation as of September 2026, because the injury is more recent and statutes of limitations have not yet expired for many patients.
Law firms including Seeger Weiss LLP continue to accept aortic aneurysm and dissection cases tied to fluoroquinolone use.
2025 Whistleblower Lawsuit Against Bayer and J&J
In 2025, Dr. Charles Bennett filed a federal whistleblower lawsuit alleging that Bayer and Johnson & Johnson used disaggregated data to fraudulently minimize the severity of fluoroquinolone side effects in their FDA regulatory submissions. The case is pending.
The Mensing Preemption Problem: Why Generic Cipro Users Face a Harder Path
One of the most significant legal obstacles in fluoroquinolone litigation is the Supreme Court’s 2011 decision in PLIVA, Inc. v. Mensing, 564 U.S. 604. In a 5-4 decision, the Court ruled that state-law failure-to-warn claims against generic drug manufacturers are preempted by federal law because generic manufacturers cannot unilaterally change their warning labels. They are required by federal law to carry identical labeling to the brand-name drug.
The practical result: if you took brand-name Cipro made by Bayer, you may have viable failure-to-warn claims against Bayer. If you took generic ciprofloxacin made by Teva, Mylan, or another manufacturer, those manufacturers are largely shielded from the same failure-to-warn theory.
This created a legally unequal landscape. Two patients could take the chemically identical drug, suffer the same injury, and have completely different legal options based solely on whether their pharmacy dispensed the brand or the generic.
Some attorneys have pursued alternative legal theories against generic manufacturers, including design defect and manufacturing defect claims, with limited success. If you took generic ciprofloxacin, a pharmaceutical injury attorney can assess whether any viable claim exists under the applicable state law.
Who Qualifies to File a Ciprofloxacin Lawsuit
Patients who may have viable claims include those who:
- Took ciprofloxacin (brand-name Cipro or generic) for any indication
- Suffered a tendon rupture (especially Achilles tendon) that required surgical repair or caused permanent disability, note that most tendon cases from before 2020 may be time-barred; consult an attorney immediately
- Developed permanent peripheral neuropathy (ongoing burning, pain, numbness, weakness in limbs) that persisted after stopping the drug, the neuropathy MDL is largely resolved but individual claims may still be possible
- Suffered an aortic aneurysm or aortic dissection within 60 days of taking ciprofloxacin, this remains the most actively litigated category
- Were not told about the black box tendon rupture warning or peripheral neuropathy warning before being prescribed the drug
- Were prescribed ciprofloxacin for a routine infection (sinusitis, uncomplicated UTI, bronchitis) when safer alternatives existed, in violation of FDA guidance
Statute of Limitations for Ciprofloxacin Lawsuits
Most states impose a 2 to 3 year statute of limitations for pharmaceutical product liability claims, measured from the date of injury or from the date the patient discovered (or should have discovered) that their injury was caused by the drug.
The discovery rule is critical in fluoroquinolone cases because patients often do not connect a tendon rupture or neuropathy to a drug they stopped taking months or years earlier. The clock may not start until a physician makes the connection or the patient becomes aware of the lawsuits.
However, statutes of limitations for tendon and neuropathy claims from before 2020 have likely expired in many states. An Oklahoma appeals court in 2024 upheld dismissal of a Levaquin neuropathy case filed outside that state’s two-year window, despite the plaintiff’s severe and documented injuries.
Aortic aneurysm claims tied to the December 2018 FDA warning may still fall within the limitations period in many states, depending on when the injury occurred and when the patient connected it to ciprofloxacin. Do not wait. Consult an attorney immediately.
What to Do If You Were Harmed by Ciprofloxacin
Step 1: Get your medical records. Obtain records documenting your ciprofloxacin prescription, the dates you took it, and records documenting your diagnosis of tendon rupture, neuropathy, aortic aneurysm, or dissection.
Step 2: Document the connection. Note whether the injury occurred during or after your ciprofloxacin course. Aortic events within 60 days of taking the drug are particularly significant. Save all prescription bottles and packaging.
Step 3: Report to the FDA. File a MedWatch adverse event report at fda.gov/safety/medwatch. Your report contributes to the ongoing safety record and is part of the evidence in ongoing litigation.
Step 4: Consult a pharmaceutical injury attorney. Most firms handling fluoroquinolone cases work on contingency, meaning no fee unless you recover. Act quickly because statutes of limitations are real and unforgiving.
Step 5: Do not stop ciprofloxacin without medical guidance if you are currently taking it. If you are concerned about a current prescription, call your prescribing physician to discuss alternatives. Do not abruptly stop an antibiotic course without medical input.
Is There a Class Action for Ciprofloxacin
There is no open ciprofloxacin class action settlement accepting consumer claims as of September 2026. The tendon rupture MDL and peripheral neuropathy MDL are both largely resolved through confidential individual settlements. Aortic aneurysm cases are being pursued as individual lawsuits.
Patients with aortic or active neuropathy claims should pursue individual pharmaceutical claims rather than waiting for a class settlement. Individual cases with severe, well-documented injuries typically recover more than class action distributions. Check open class action settlements for any future developments.
Frequently Asked Questions About Ciprofloxacin Side Effects
What are the most serious side effects of ciprofloxacin?
The most serious documented side effects of ciprofloxacin are tendon rupture (including Achilles tendon), permanent peripheral neuropathy (irreversible nerve damage causing burning pain, numbness, and weakness), aortic aneurysm or dissection (a life-threatening tear in the main body artery), dangerous psychiatric effects including suicidal ideation and hallucinations, life-threatening hypoglycemia in diabetic patients, and severe worsening of myasthenia gravis. The FDA has issued two black box warnings and multiple additional safety communications about these risks.
Does ciprofloxacin cause permanent nerve damage?
Yes. The FDA added a black box warning in August 2013 specifically stating that ciprofloxacin and other fluoroquinolones can cause peripheral neuropathy that may be irreversible. Symptoms include burning pain, tingling, numbness, and weakness in the arms and legs. The warning replaced earlier labeling that described neuropathy as rare and reversible, characterizations that litigation revealed to be inconsistent with what manufacturers knew internally.
Can ciprofloxacin rupture your Achilles tendon?
Yes. The FDA added a black box warning in 2008 specifically naming Achilles tendon rupture as a documented risk. The rupture can occur during treatment or months after finishing the drug. Patients over 60, those taking corticosteroid medications, and organ transplant recipients face the highest risk. The rupture can be sudden and occur during ordinary activities such as walking.
Can ciprofloxacin cause an aortic aneurysm?
Research and the FDA’s own December 2018 safety communication indicate a significant association between fluoroquinolone use (including ciprofloxacin) and aortic aneurysm and dissection. The FDA identified 71 reported cases and required new warning language on all fluoroquinolone labels. Multiple peer-reviewed studies, including a 2025 multinational study in The Lancet, have confirmed the association. The highest-risk window appears to be within 60 days of taking the drug.
Is there a lawsuit against Bayer for ciprofloxacin?
Yes. Thousands of lawsuits have been filed against Bayer (the manufacturer of brand-name Cipro) and related manufacturers. Federal multidistrict litigation consolidated cases for tendon rupture and peripheral neuropathy injuries. Those MDLs are largely resolved through confidential settlements. Aortic aneurysm and dissection cases are currently the most active area of ciprofloxacin litigation and continue to be accepted by plaintiff law firms.
Can I sue if I took generic ciprofloxacin instead of brand-name Cipro?
Possibly, but with significant limitations. The U.S. Supreme Court ruled in PLIVA v. Mensing (2011) that generic drug manufacturers cannot be sued for failure to warn under state law because federal law requires them to use the same label as the brand-name drug, which they cannot change unilaterally. Some alternative legal theories (design defect, manufacturing defect) may still apply in some states. Consult a pharmaceutical injury attorney to assess the viability of a claim based on your specific circumstances and state.
What is fluoroquinolone toxicity or “being floxed”?
Fluoroquinolone-associated disability (FQAD), sometimes called “being floxed,” describes a multi-system adverse reaction in which a patient experiences simultaneous damage to tendons, nerves, muscles, joints, and other body systems after taking a fluoroquinolone antibiotic. The FDA defines FQAD as serious adverse effects lasting at least 30 days after the final dose. Patients have reported symptoms lasting years. The mechanism is believed to involve mitochondrial damage and collagen disruption caused by the drug.
How long do ciprofloxacin side effects last?
Common side effects such as nausea and diarrhea typically resolve within days of stopping the drug. Tendon inflammation may last weeks to months. Peripheral neuropathy can be permanent. The FDA’s documented average duration of fluoroquinolone-associated disability was 14 months, with some cases lasting far longer. Aortic damage, once it occurs, is permanent and can be life-threatening regardless of whether the drug is stopped.
Should I still take ciprofloxacin if my doctor prescribes it?
Do not stop or refuse prescribed medication without discussing it with your doctor first. However, it is appropriate to ask your prescribing physician whether ciprofloxacin is necessary for your specific infection or whether a safer antibiotic would be effective. The FDA has specifically stated that ciprofloxacin should not be used for uncomplicated sinusitis, uncomplicated UTIs, or bronchitis when safer alternatives exist. If you are over 60, take corticosteroids, have cardiovascular disease or a history of aortic aneurysm, or have myasthenia gravis, ask explicitly about alternatives.
What injuries qualify for a ciprofloxacin lawsuit?
The injuries currently forming the basis of active ciprofloxacin lawsuits are aortic aneurysm and aortic dissection (the most active litigation area), permanent peripheral neuropathy requiring ongoing treatment, and Achilles or other tendon rupture requiring surgery. Tendon and neuropathy cases from before 2020 may face statute of limitations barriers. Consult an attorney without delay if you or a family member suffered any of these injuries after taking ciprofloxacin.
This article is for informational purposes only and does not constitute legal or medical advice. If you have been harmed by ciprofloxacin, consult a licensed attorney in your state. Do not change your medication regimen without speaking to your physician.
Related: Open Class Action Settlements | Dilantin Side Effects | What Is Farxiga | Personal Injury Statute of Limitations